Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Head & Neck 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Head and Neck Neoplasms 2Urogenital Neoplasms 1Sarcoma 1Nasopharyngeal Carcinoma 1Melanoma 1Lung Neoplasms 1Hearing Loss 1Colorectal Neoplasms 1Carotid Stenosis 1Carcinoma, Squamous Cell 1Breast Neoplasms 1

Interventions

pembrolizumab 11Nivolumab 6Cetuximab 5Gemcitabine 4Filgrastim 4Cisplatin 4Carboplatin 4tislelizumab 3Radiosurgery 3Ipilimumab 3Injections 3Fluorouracil 3Docetaxel 3Cyclophosphamide 3Bortezomib 3toripalimab 2spartalizumab 2poly ICLC 2pazopanib 2entrectinib 2durvalumab 2cemiplimab 2belinostat 2atezolizumab 2Temozolomide 2Surveys and Questionnaires 2Riluzole 2Peripheral Blood Stem Cell Transplantation 2Oncolytic Virotherapy 2Etoposide 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma × Atorvastatin × Head & Neck × Clear all
NCT01259284 2012-08-07

Fish Oil Versus Statins Versus Placebos in Reducing Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer

M.D. Anderson Cancer Center

Phase 2/3 Terminated
2 enrolled 4 charts
BreastDermatologicGastrointestinalHead & NeckSarcomaThoracic

Breast Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Sarcoma, Urogenital Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡